Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution

Int J Lab Hematol. 2011 Oct;33(5):451-6. doi: 10.1111/j.1751-553X.2011.01311.x. Epub 2011 Mar 21.

Abstract

Introduction: Protein C (PC) Asn2Ile is a rare pro-thrombotic variant in which loss of anticoagulant function in vivo is likely to result from defective PC binding to the endothelial PC receptor and phospholipid.

Methods: To characterize the consequences of this functional defect on the diagnostic performance of commercial PC activity assays, we performed one antigen, three chromogenic and three coagulometric assays on plasma from a subject who was heterozygous for the PC Asn2Ile substitution.

Results: As anticipated, the PC antigen (96.2 IU/dl) and chromogenic PC activity assays (98.4 IU/dl) were insensitive to PC Asn2Ile, which has intact enzymatic activity and is secreted normally. There was a marked reduction in apparent PC activity by STACLOT coagulometric assay (50.4 IU/dl). However, there was only a small reduction in apparent PC activity by CRYOcheck Clot C assay (69.5 IU/dl) and by HemosIL ProClot assay, the PC activity was within the laboratory reference range (91 IU/dl). This discrepancy between coagulometric assays could not be explained by lupus anticoagulant, activated PC resistance or elevated plasma factor VIII activity.

Conclusion: We demonstrate that coagulometric assays are not equally sensitive to clinically important functional defects of PC and that multiple assays may be required to identify all variants.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amino Acid Substitution / genetics
  • Blood Coagulation Tests*
  • Female
  • Heterozygote
  • Humans
  • Protein C / genetics
  • Protein C / immunology
  • Protein C / metabolism*
  • Protein C Deficiency / blood*
  • Protein C Deficiency / diagnosis*

Substances

  • Protein C